证券代码：603990 证券简称：麦迪科技 公告编号：2025-043 苏州麦迪斯顿医疗科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、 闲置募集资金现金管理总体情况 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第四届董事会第三十一次会议、第四届监事会第十五次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在确保不影 响募集资金投资项目进度和募集资金安全的前提下，对暂时闲置的部分募集资金 不超过人民币 2 亿元（包含本数）进行现金管理，余额在上述额度内，资金可以 滚动使用，用于购买单笔期限最长不超过 12 个月（含 12 个月）的结构性存款等 安全性高的保本型产品，不得用于证券投资。公司董事会、监事会及保荐机构已 分别对前述事项发表了同意的意见。具体内容详见公司于 2025 年 4 月 30 日披露 的《关于使用部分闲置募集资金进行现金管理的公告》(公告编号：2025-025)。 公司使用闲置募集资金购买的产品不存在逾期未收回的情况。 ...

（一）变更前经营范围： 研发医疗器械、计算机软硬件及通信技术，医用机器人导航系统，微创手术 平台系统，机电一体化产品；提供计算机系统集成、信息网络及数据处理的技术 服务、技术咨询、技术转让；建筑智能化、净化工程的设计、施工及工程咨询； 组装生产微型计算机；销售本公司自主研发生产的产品；从事医疗器械、计算机 软硬件、电子产品的批发、进出口、佣金代理（拍卖除外）、自有房屋租赁及相 关业务。（依法须经批准的项目，经相关部门批准后方可开展经营活动）许可项 目：第二类医疗器械生产；第三类医疗器械经营；第三类医疗器械生产。（依法 须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部 门批准文件或许可证件为准）一般项目：第二类医疗器械销售；第一类医疗器械 销售；第一类医疗器械生产；节能管理服务；合同能源管理；运行效能评估服务； 在线能源监测技术研发（除依法须经批准的项目外，凭营业执照依法自主开展经 营活动） 证券代码：603990 证券简称：麦迪科技 公告编号：2025-041 苏州麦迪斯顿医疗科技股份有限公司 关于增加经营范围及修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 ...

麦迪科技 2025 年第一次临时股东大会会议材料 苏州麦迪斯顿医疗科技股份有限公司 2025 年第一次临时股东大会 苏州麦迪斯顿医疗科技股份有限公司 2025 年第一次临时股东大会会议资料目录 | 2025 | | 年第一次临时股东大会会议须知 | 3 | | --- | --- | --- | --- | | 2025 | 年第一次临时股东大会议程 | | 5 | | 议案 | 1：关于公司 | 2024 年度未弥补亏损达到实收股本总额三分之一的议案 | 6 | | 议案 | | 2：关于增加经营范围及修订《公司章程》的议案 | 7 | 麦迪科技 2025 年第一次临时股东大会会议材料 苏州麦迪斯顿医疗科技股份有限公司 2025 年第一次临时股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证 大会的顺利进行，根据《中华人民共和国公司法》《中华人民共和国证券法》、中 国证监会《上市公司股东大会规则》以及《公司章程》《股东大会议事规则》的 相关规定，特制定 2025 年第一次临时股东大会会议须知。 一、本次会议设立股东大会会务组，具体负责会议期间的组织及相关会务工 作。 二、为 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2025-042 苏州麦迪斯顿医疗科技股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 30 日 14 点 30 分 召开地点：江苏省苏州市工业园区归家巷 222 号麦迪科技会议室 股东大会召开日期：2025年6月30日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (一)股东大会类型和届次 2025年第一次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 30 日 | 序号 | 议案名称 | 投票股东类型 | | --- | --- | --- | | | | 股股东 A ...

苏州麦迪斯顿医疗科技股份有限公司 第四届监事会第十六次会议决议公告 证券代码：603990 证券简称：麦迪科技 公告编号：2025-038 监事会认为：公司及子公司使用自有资金支付募投项目部分款项并以募集资 金等额置换事项，履行了必要的决策程序，制定了相应的操作流程，优化了募投 项目款项支付方式，有利于提高公司资金的使用效率，降低公司及子公司财务成 本，符合公司及全体股东的利益。该事项的内容及程序符合相关法律、法规、规 范性文件及公司相关制度的规定。同意《关于使用自有资金支付募投项目部分款 项并以募集资金等额置换的议案》。 具体内容详见公司同日披露的《关于使用自有资金支付募投项目部分款项并 以募集资金等额置换的公告》。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 特此公告。 苏州麦迪斯顿医疗科技股份有限公司监事会 2025 年 6 月 14 日 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"、"麦迪科技"）第 四届监事会第十六次会议于 ...

二、董事会会议审议情况 （一）审议并通过了《关于公司未弥补亏损达到实收股本总额三分之一的议案》； 具体内容详见公司同日披露的《麦迪科技关于公司 2024 年度未弥补亏损达 到实收股本总额三分之一的公告》。 表决结果：同意 5 票；反对 0 票；弃权 0 票。 证券代码：603990 证券简称：麦迪科技 公告编号：2025-037 苏州麦迪斯顿医疗科技股份有限公司 第四届董事会第三十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"、"麦迪科技"）第 四届董事会第三十二次会议于 2025 年 6 月 13 日以通讯表决的方式召开。本次董 事会会议通知于 2025 年 6 月 12 日以邮件形式发出，经全体董事同意，豁免本次 董事会提前书面通知的要求。会议由董事长陈宁先生召集并主持，会议应出席董 事 5 名，实际出席董事 5 名，公司监事会成员及高级管理人员列席了本次会议。 会议召集及召开方式符合《中华人民共和国公司法》和《苏州麦迪斯顿医疗科 ...

Core Insights - The Shanghai International Elderly Care, Aids, and Rehabilitation Medical Expo showcases advancements in elderly care technology, with around 500 exhibitors from 16 countries [1][6] - The introduction of the "Xiao Mai" robot by Suzhou Meidi Technology is a highlight, designed specifically for elderly care scenarios, featuring capabilities such as visual recognition and voice interaction [3][5] Industry Overview - The aging population in China has surpassed 300 million, leading to a burgeoning silver economy projected to reach 30 trillion yuan, making "smart elderly care" a pressing social demand [6] - The establishment of Suzhou Youmai Robot Co., a joint venture between Meidi Technology and UBTECH, aims to focus on the development and industrialization of service robots in healthcare and elderly care [6] Product Features - "Xiao Mai" is a lightweight and agile robot, standing at 1.63 meters and weighing 43 kilograms, capable of performing various tasks such as greeting, health education, emotional interaction, and behavior monitoring [5][6] - The robot operates on a comprehensive solution that integrates a specialized AI model for elderly care with a smart management platform, facilitating data integration across healthcare systems and enhancing service delivery [6][8] Market Application - "Xiao Mai" is currently undergoing application testing in several elderly care institutions in Zhejiang and Shanghai, with plans to develop a smart elderly care solution characterized by platform-driven and model-enabled collaboration [8]

Investment Rating - The report indicates a positive investment outlook for the elderly care robot industry, projecting significant growth due to increasing demand and supportive policies [3][5]. Core Insights - The aging population in China is expected to reach 220 million by the end of 2024, leading to a critical shortage of human resources in elderly care, with only about 20,000 certified caregivers available [3][18]. - The market for elderly care robots is projected to exceed 15 billion yuan in the short term, with a potential to surpass 150 billion yuan by 2029, driven by the increasing need for rehabilitation, nursing, and companionship solutions [5][27]. - The report highlights the importance of policy support in driving the development of the elderly care robot industry, with multiple initiatives launched since 2021 to promote innovation and application in this sector [19][20]. Summary by Sections Policy Guidance - The report emphasizes the dual pressure of supply and demand in the elderly care sector, creating new opportunities for robotic solutions [13][14]. - Various national and local policies have been introduced to support the development of elderly care robots, reflecting the government's commitment to addressing aging issues [17][19]. Market Insights - The elderly population is increasingly characterized by disabilities, chronic illnesses, and loneliness, leading to diverse needs for daily care, medical rehabilitation, and emotional support [23][29]. - Rehabilitation robots dominate the market with a 60% share, while nursing robots account for 34%, and companionship robots represent 6% [26][31]. - The market for elderly care robots in China has grown rapidly, from 3.8 billion yuan in 2020 to 6.6 billion yuan in 2023, with a compound annual growth rate (CAGR) of 20.2% [27][34]. Industry Analysis - The elderly care robot ecosystem is built on a closed-loop system comprising perception, decision-making, execution, and interaction, with a focus on high-precision sensors and joint transmission components [4][12]. - Key players in the rehabilitation robot sector include Fourier, New松, and Estun, while companies like Meditech and Ubiquiti are significant in the nursing robot market [4][36]. - The integration of various industry chains, including healthcare, smart home, and robotics, is crucial for the development of elderly care robots [5][19]. Company Analysis - Fourier and Meditech are noted for their strong positions in the rehabilitation robot market, while Ubiquiti and New松 are leading in nursing robots [4][36]. - The report suggests continuous tracking of companies that are forming partnerships to create comprehensive elderly care solutions, such as Meditech's collaboration with Ubiquiti and Huawei [5][31].

Core Viewpoint - The issuance of the "Notice" aims to accelerate the application and development of intelligent elderly care service robots in response to the increasing challenges of population aging through policy guidance and resource integration [3][4]. Summary by Relevant Sections Event - On June 9, 2025, the Ministry of Industry and Information Technology and the Ministry of Civil Affairs jointly released the "Notice on Conducting Pairing Attacks and Scene Application Pilot Work for Intelligent Elderly Care Service Robots" [2]. Main Content - The "Notice" emphasizes three main areas: 1. Establishing partnerships between enterprises and elderly care institutions to address five major needs, including disability care and emotional companionship, while overcoming shortcomings in safety and reliability. 2. Conducting scene application verification, requiring 200 households to validate home scenarios and deploying over 200 sets of equipment; for community/institution scenarios, covering more than 20 communities or elderly care institutions with at least 20 sets of equipment, with a verification period of no less than six months. 3. Improving standards and evaluation systems, requiring pilot units to jointly formulate standards for aging suitability and safety evaluation to enhance product reliability and intelligence [3][4]. Background - The aging process in China is deepening, with the population aged 60 and above expected to exceed 300 million by the end of 2024, accounting for 22% of the total population. There is a shortage of 5.5 million elderly care workers, particularly for disabled elderly care needs. The elderly care robot market has significant potential, but two core issues must be addressed: low public awareness and high product prices, along with insufficient intelligence [4]. - The silver economy is projected to reach approximately 7 trillion yuan in 2024, accounting for 6% of GDP, and is expected to grow to 30 trillion yuan by 2035, representing 10% of GDP. The domestic elderly care robot market is anticipated to exceed 30 billion yuan in 2024 and reach 50 billion yuan in 2025, with a compound annual growth rate of over 30% [4]. Investment Suggestions - The policy aims to bridge the gap between technology and commercialization, transitioning the elderly care robot industry from "concept innovation" to "scale application." The industry is recommended for attention, with specific stocks suggested for consideration [5][6].

Core Viewpoint - The recent policy announcement by the Ministry of Industry and Information Technology and the Ministry of Civil Affairs aims to promote the development of smart elderly care service robots, which is expected to significantly boost the industry and accelerate technology implementation and market penetration [1][2]. Industry Overview - China's aging population is accelerating, leading to a surge in demand for elderly care services, while resources remain scarce. The rapid development of AI technology presents new solutions for the elderly care industry, making the smart elderly care robot market a focal point [2]. - According to a report by Founder Securities, the market size of the smart elderly care robot industry is projected to reach approximately 7.9 billion yuan in 2024, with rehabilitation robots accounting for the largest share at 45%. Emotional companionship robots are expected to grow at a remarkable annual rate of 120%, with the market size potentially exceeding 50 billion yuan by 2025 [2]. Company Developments - Several listed companies are actively entering the smart elderly care robot sector. For instance, Xilong Health has indicated that smart rehabilitation assistive devices, including smart wheelchairs and exoskeleton robots, are key development areas, although no mature products have been launched yet [2]. - Ousheng Electric has gained a competitive edge with its new intelligent nursing robot, which can automatically sense and identify the status of disabled patients, significantly improving care efficiency and patient comfort [2]. - Medisdon Medical Technology has formed strategic partnerships to integrate medical information technology with elderly care robotics, aiming to create a comprehensive solution platform for smart elderly care [3]. Market Challenges - Despite the promising outlook for the smart elderly care robot industry, there are challenges such as the need for improved environmental perception and adaptability in complex settings, as well as high production costs due to expensive raw materials [5][6]. - The market is becoming increasingly competitive, with many companies entering the field, leading to potential homogenization of products. Some companies are rushing to launch products without mature technology, resulting in varying product quality [5][6]. - Companies must focus on continuous R&D investment, mastering core technologies, and optimizing cost control to succeed in this competitive landscape [6].